Advertisement

Ads Placeholder
Loading...

Dicerna Pharmaceuticals, Inc.

DRNA•NASDAQ
Healthcare
Biotechnology
$38.22
$0.00(0.00%)
U.S. Market is Open • 12:15

Dicerna Pharmaceuticals, Inc. (DRNA) Stock Overview

Explore Dicerna Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio-25.26
EPS (TTM)N/A
ROE-0.78%
Fundamental Analysis

AI Price Forecasts

1 Month$41.44
3 MonthsN/A
1 Year Target$60.66

DRNA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Dicerna Pharmaceuticals, Inc. (DRNA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $60.66.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -25.26 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
75.72%
All-Time (Max) Change
-16.91%

Contact Information

https://dicerna.com
16176218097
33 HAYDEN AVENUE, Lexington, MA, 02421

Company Facts

3,020 Employees
IPO DateJan 30, 2014
CountryUS

Frequently Asked Questions